Clinical Trial Update: A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection [Phase 2]

View source ↗

Summary

Clinical Trial Update reports on a Phase 2 study of RO5217790 in participants with high-grade cervical intraepithelial neoplasia associated with high-risk HPV; …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Intraepithelial Neoplasia

Drugs mentioned

• RO5217790

Snippet

Sponsor: Hoffmann-La Roche | Conditions: Cervical Intraepithelial Neoplasia | Phase 2 | Status: COMPLETED